Daiken Biomedical's (TPE:7780) Australian subsidiary, Daiken Investment One Australia, will acquire a real estate property in Brisbane for AU$81.1 million, according to a Tuesday filing with the Korean Exchange.
The property comprises a land area of 4,564 square meters and a building area of 13,417 square meters.